Anti-HGF/SF Antibody (TAK-701) represents a highly specialized humanized monoclonal antibody specifically engineered to target the human hepatocyte growth factor which acts as a pivotal ligand for the c-Met receptor tyrosine kinase across various malignancies, effectively facilitating the measurable neutralization of HGF-induced signaling to evaluate its role in cancer cell survival and metastasis during strictly monitored laboratory observation periods.
Target:
Others
T9901A-1423
* VAT and and shipping costs not included. Errors and price changes excepted
